RxDoctor Payments DataLook up a doctor →

Matthew Goldblatt, MD

Surgery · Milwaukee, WINPI 1790771517

Payments from drug & device makers

$897,664in general payments, 2019–2025

Across 612 payments — averaging $1466.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • W. L. Gore & Associates, Inc.$694K
  • Medtronic$89K
  • Covidien LP$77K
  • Intuitive Surgical$30K
  • Davol Inc.$5K
  • Surgical Specialties Corporation (US), Inc. (dba Corza Medical)$1K
  • plus $620 from 5 others
$11,813in research payments, 2019–2025

Across 10 payments — averaging $1181.25 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$7K
  • Covidien LP$5K

What the payments were for

  • Consulting fees$280,03347%
  • Speaking & faculty fees$205,05235%
  • Travel & lodging$63,77611%
  • Food & beverage$16,8733%
  • Education$28,0285%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$897,664 in reported general payments places this provider in the 95th percentile of 499 surgery providers in Wisconsin.

See all surgery providers in Wisconsin

Medicare billing

Part B allowed, 2024
$47,591
Medicare patients
104
Services billed
193

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Magnesium Sulfate15$113
Oxycodone Hcl20$31

Paid to pharmacies, not to this prescriber.

Other surgery in Milwaukee

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →